BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS




Industry
Biotechnology






 Company News
Amarantus BioSciences, Inc. To Present At The Fourth Annual SeeThru Equity Microcap Investor Conference On May 28, 2015 5/26/2015 7:57:17 AM
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015 6:11:49 AM
Amarantus BioSciences, Inc. Enters Into CRO Agreement With Chiltern International Ltd. To Commence Phase IIb Clinical Development Of Eltoprazine In Parkinson's Disease Levodopa-Induced Dyskinesia 5/21/2015 11:01:01 AM
Amarantus BioSciences, Inc. Reports First Quarter 2015 Financial Results And Business Overview 5/20/2015 11:49:12 AM
Amarantus BioSciences, Inc. To Present At Two Upcoming Investor Conferences 5/20/2015 8:24:33 AM
Amarantus BioSciences, Inc. Announces Successful Delivery And Distribution Of MANF In Preclinical Model To Brain Areas Involved In Parkinson's Disease 5/15/2015 7:07:14 AM
Amarantus BioSciences, Inc. Enters Into CGMP Manufacturing Agreement With Catalent Biologics For Production Of MANF For Human Clinical Studies 5/14/2015 7:46:35 AM
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Methods Of Administration And Compositions In The Treatment Of Parkinson's Disease 5/13/2015 12:40:09 PM
Amarantus BioSciences, Inc. Reports Preliminary Data From Blood-Based Version Of Msprecise Diagnostic For Multiple Sclerosis 5/11/2015 8:20:55 AM
Amarantus BioSciences, Inc. Announces The Presentation Of Data Showing MANF's Positive Effect On Retinal Function At Association for Research in Vision & Ophthalmology Annual Meeting 5/7/2015 12:00:57 PM
12345678910...